BridgeBio PharmaBBIO

BridgeBio Pharma

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Mr. Neil Kumar, PhD

$5.5B

Market Cap • 20/05/2024

2019

(há 5 anos)
Fundação

2019

(5 years ago)
IPO

NASDAQ

Listagem
Flag of US

Palo Alto

Sede • California

396

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

BBIOSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-2%

1 dia

17/05/2024

4%

1 semana

13/05/2024

18%

1 mês

22/04/2024

115%

1 ano

22/05/2023

10 anos

Histórico